Bayer Looks To Emerging Markets For Growth

Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey as markets in which it will target sales growth. The combined pharmaceutical market of these seven countries reached a value of US$126.05bn in 2009 and by 2014 it is expected to reach US$258.89bn, equating to a compound annual growth rate (CAGR) of 15.48%.

To read the full article, please choose one of the following options: